These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 36092861)

  • 1. Gut and obesity/metabolic disease: Focus on microbiota metabolites.
    Lin K; Zhu L; Yang L
    MedComm (2020); 2022 Sep; 3(3):e171. PubMed ID: 36092861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of adipose tissue metabolism by microbial-derived metabolites.
    Liu W; Yang G; Liu P; Jiang X; Xin Y
    Front Microbiol; 2022; 13():1031498. PubMed ID: 36569060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.
    Gao J; Xu K; Liu H; Liu G; Bai M; Peng C; Li T; Yin Y
    Front Cell Infect Microbiol; 2018; 8():13. PubMed ID: 29468141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease.
    Zhu J; Lyu J; Zhao R; Liu G; Wang S
    Front Microbiol; 2023; 14():1272479. PubMed ID: 37822750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut-microbiota derived bioactive metabolites and their functions in host physiology.
    Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK
    Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD).
    Yoo JY; Sniffen S; McGill Percy KC; Pallaval VB; Chidipi B
    Microorganisms; 2022 Jan; 10(1):. PubMed ID: 35056557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
    Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
    Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Microbiota-Associated Metabolites in Heart Failure.
    Masenga SK; Povia JP; Lwiindi PC; Kirabo A
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota-derived metabolites in obesity: a systematic review.
    Ejtahed HS; Angoorani P; Soroush AR; Hasani-Ranjbar S; Siadat SD; Larijani B
    Biosci Microbiota Food Health; 2020; 39(3):65-76. PubMed ID: 32775123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of gut microbes in metabolic-associated fatty liver disease.
    Chen CY; Ho HC
    Tzu Chi Med J; 2023; 35(4):279-289. PubMed ID: 38035063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiota and the metabolic health of the host.
    Joyce SA; Gahan CG
    Curr Opin Gastroenterol; 2014 Mar; 30(2):120-7. PubMed ID: 24468803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
    Agus A; Clément K; Sokol H
    Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
    Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
    Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions between the intestinal microbiota and the host.
    Hertli S; Zimmermann P
    Mol Microbiol; 2022 Jun; 117(6):1297-1307. PubMed ID: 35403275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of gut microbiota metabolites on cellular bioenergetics and cardiometabolic health.
    Tomasova L; Grman M; Ondrias K; Ufnal M
    Nutr Metab (Lond); 2021 Jul; 18(1):72. PubMed ID: 34266472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes.
    Sharma M; Li Y; Stoll ML; Tollefsbol TO
    Front Genet; 2019; 10():1329. PubMed ID: 32010189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.